IMIST


Pharmaceutical product development : (notice n° 15618)

000 -LEADER
fixed length control field 01682nam a2200253 u 4500
001 - CONTROL NUMBER
control field UNI0000345
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20161124100328.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 121012s2007 XX eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0849338271 (hardcover) ($199.95)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780849338274 (hardcover)
040 ## - CATALOGING SOURCE
Original cataloging agency DCLC
040 ## - CATALOGING SOURCE
Modifying agency IMIST
Description conventions AFNOR
041 1# - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1 V22
245 #0 - TITLE STATEMENT
Title Pharmaceutical product development :
Remainder of title in vitro-in vivo correlation /
Statement of responsibility, etc Dakshina Murthy Chilukuri, Gangadhar Sunkara, David Young.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc [S.l.] :
Name of publisher, distributor, etc INFRMA-HC,
Date of publication, distribution, etc 2007.
300 ## - PHYSICAL DESCRIPTION
Extent 204 p. ;
Dimensions 23 cm.
490 1# - SERIES STATEMENT
Series statement Drugs and the pharmaceutical sciences.
500 ## - GENERAL NOTE
General note During the last two decades, the pharmaceutical industry has been under pressure to reduce development costs and the time needed to bring drugs to market in order to maximize return on investment and bring treatments to patients sooner. To meet these ends, pharmaceutical scientists working in the differing areas of pharmacy, pharmaceutics, and pharmacokinetics are collaborating to address physicochemical and biological issues in the early stages of development to avoid problems in later stages. In Vitro-In Vivo Correlation (IVIVC) is a multidisciplinary tool that has been successfully applied in testing the effectiveness of a drug substance. The only comprehensive guide available on IVIVC, this source illustrates the emerging importance of IVIVC in the drug development process, and covers the most recent advances and regulatory perspectives on the role of IVIVC in the pharmaceutical industry.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chilukuri,, Dakshina Murthy.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sunkara,, Gangadhar.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Young,, David.
Exemplaires
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
        La bibliothèque des Sciences Médicales et Pharmaceutiques La bibliothèque des Sciences Médicales et Pharmaceutiques   10439   615.1 CHI 0000000010633 11/24/2016 11/24/2016 Livre
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha